Executive Summary

Between 2025 and 2035 the Personalized Nutrition Products Market is projected to expand from 16.3 USD Billion to 60.9 USD Billion, a CAGR of 14.06%. This trajectory reflects a shift from generic supplementation toward biomarker-driven regimens delivered through subscription and app-based channels rather than shelf purchase.

Growth is anchored in two mechanisms: wider consumer access to at-home biomarker tools – continuous glucose monitors, wearable biosensors, and DNA testing kits – and rising uptake of disease-based formulations alongside standard wellness supplements. GDPR data-trust frameworks in Europe and expanding direct-to-consumer subscription models are reinforcing adoption.

North America led with a 43.9% share in 2025, on venture funding and regulatory clarity, while Asia Pacific is the fastest-growing region at a 14.34% CAGR. Active Measurement products, capturing 57.48% of the market, dominate the product-type axis over static, questionnaire-based Standard Measurement offerings; Direct-to-Consumer remains the leading end-user channel at 62.85% share.

Category expansion faces a structural constraint in data-privacy compliance costs tied to biomarker collection, which weigh disproportionately on smaller entrants. The competitive base is moderately consolidated, with established wellness brands and diagnostics-linked entrants competing alongside newer subscription-first challengers for share of the direct-to-consumer channel.

Key Takeaways

• The Personalized Nutrition Products Market is valued at USD 18.62 Billion in 2026 and is projected to reach USD 60.863 Billion by 2035, a 14.06% CAGR.
• Active Measurement led product-type segmentation with a 57.48% share in 2025.
• Standard Measurement is the fastest-growing product type, posting a 15.95% CAGR through 2035.
• North America held 43.92% of the market in 2025, valued at USD 7.168 Billion.
• Continuous glucose monitors and wearable biosensors, which track biomarkers in real time, are the strongest driver of category growth.
• Rising customer-acquisition costs in the Direct-to-Consumer channel, which holds a 62.85% share, are the principal restraint on margin expansion.

Market Definition and Scope

The personalized nutrition products market covers supplements, vitamin blends, and diet plans customized to an individual’s biomarkers or self-reported inputs. Active measurement products – continuous glucose monitors, wearable biosensors, smart patches, and smart rings – track real-time data, while standard measurement relies on DNA/genetic testing kits, blood-based tests, microbiome/gut testing kits, and saliva-based tests submitted once. The boundary spans standard supplements and disease-based formulations, distributed direct-to-consumer, through wellness and fitness centres, and via hospitals and clinics where physicians prescribe tailored regimens.

Excluded are mass-market supplements and vitamins sold without individualized biomarker or questionnaire input, generic meal-kit and meal-delivery services, and standalone fitness or diet-tracking apps that recommend behaviour without shipping a formulated product. Prescription pharmaceuticals and medical foods regulated as drugs rather than supplements also sit outside the boundary.

Growth Drivers and Restraints

Market Trends

Biomarker Data Scale Is Becoming the Core Competitive Moat

Viome’s AI recommendation engine is trained on gene-expression data from over one million samples across 106 countries, Amway’s Korean programme rests on roughly 95,000 gut microbiome samples, and Nestle is running AI analysis over roughly 120,000 recipes – disclosures reported between April and August 2026 showing that personalization accuracy now scales with database size rather than marketing spend. Brand owners without a proprietary sample base are effectively locked out of formulation-level personalization and pushed toward licensing or acquisition instead. Through 2035, this raises the capital and data threshold for new entrants and concentrates share among data-rich incumbents, reinforcing subscription-based direct-to-consumer testing as the primary channel for capturing repeat biological data.

Legacy Direct-Selling Brands Are Buying Personalization Capability Rather Than Building It

Herbalife will pay USD 10 Million at closing, within a total of USD 55 Million payable over five years, plus up to USD 95 Million in performance-based payments, for Bioniq – a blood-biomarker personalization platform serving hundreds of thousands of users, in a deal announced 26 March 2026. The acquisition folds Bioniq’s testing capability into an existing direct-selling network rather than leaving it D2C-only, and follows Herbalife’s prior purchases of Pro2col and Link BioSciences, pointing to a repeatable playbook. Legacy direct-selling and mass-market brand owners are the buyers; smaller biomarker-personalization technology firms are the targets. Expect consolidation to keep moving personalization technology into established distributor channel mix rather than standalone D2C brands through the forecast period.

Sugar-Free and Protein-Dense Reformulation Is Pulling Personalization Into Mass Channels

Liquid I.V. Sugar-Free, launched in the US in 2023, now accounts for over 30% of the brand’s total US sales, while the US functional water market ran at approximately USD 750 Million in monthly sales with the enhanced water segment growing 13% between 2023 and 2024. Adjacent protein supplement sales reached USD 8.6 Billion in 2025, up 12.4% in dollars and 13% in units year on year, reported in March 2026. Formulation cues once specific to premium personalized brands – sugar reduction, protein density – are migrating into mass and mid-tier hydration and snack aisles. This widens purchase frequency beyond the subscription-first customer base and pulls the category’s price-pack architecture toward broader retail distribution through 2035.

Segment Analysis

By Product Type

• Active Measurement (largest, 57.48% share) – Personalized nutrition products built on data from wearables, biosensors, or at-home test kits that track biomarkers such as glucose, sleep, or activity in real time to tailor recommendations
• Continuous Glucose Monitors

• Real-Time CGM
• Intermittently Scanned CGM

• Wearable Biosensors
• Smart Patches
• Smart Rings/Wearable Trackers
• Standard Measurement (fastest-growing, 15.95% CAGR) – Personalized nutrition products based on static inputs like questionnaires, health history, or lab reports submitted once to generate a customized diet or supplement plan

• DNA/Genetic Testing Kits
• Blood-Based Tests
• Microbiome/Gut Testing Kits
• Saliva-Based Tests

Active Measurement accounted for 57.48% of the Personalized Nutrition Products Market in 2025. Continuous glucose monitors, wearable biosensors, and smart patches lead the axis because real-time biomarker feedback lets brands issue same-day recommendation changes, a purchase-frequency advantage that static test kits cannot match, and device ownership locks buyers into subscription renewal rather than a single transaction. Standard Measurement is the fastest-growing product type, expanding at a 15.95% CAGR through the forecast period. Falling prices for DNA, microbiome, and blood-based test kits are widening household penetration among first-time buyers unwilling to commit to wearable hardware, and telehealth partnerships are converting one-off test purchases into repeat panel orders as retesting cadences lengthen average basket size over a subscription term.

By Application

• Standard Supplements (largest, 49.72% share) – Personalized vitamin, mineral, and nutrient blends formulated for general wellness, energy, or preventive health rather than a diagnosed medical condition

• Vitamins & Minerals
• Proteins & Amino Acids
• Probiotics & Prebiotics
• Herbal & Botanical Supplements
• Disease-based Formulations (fastest-growing, 14.72% CAGR) – Nutrition products tailored to an individual’s biomarkers or genetics to manage or support treatment of a specific diagnosed disease or condition

• Diabetes Management
• Cardiovascular Health
• Weight Management
• Digestive Health
• Bone & Joint Health

Standard Supplements held 49.72% of the market in 2025, the largest application segment. Vitamins, proteins, and probiotic blends lead because they serve a broad wellness-conscious buyer base without requiring a diagnosed condition, giving brands the widest addressable household penetration and the shortest path from quiz result to cart. Disease-based Formulations is the fastest-growing application, posting a 14.72% CAGR. Diabetes management and cardiovascular formulations are pulling share as biomarker testing becomes routine enough to surface undiagnosed risk factors, and clinicians and dietitians are increasingly prescribing personalized regimens that previously relied on generic over-the-counter supplements, lifting average order value even as unit volume in the segment trails general wellness.

By End User

• Direct-to-Consumer (largest, 62.85% share) – The channel through which personalized nutrition brands sell customized supplements, meal plans, or vitamin packs directly to individual buyers via online quizzes, apps, or subscriptions

• Subscription-based Services
• One-time Purchase
• Wellness & Fitness Centres (fastest-growing, 14.18% CAGR) – Gyms, spas, and wellness studios that offer personalized nutrition assessments and tailored supplement or diet plans as part of member health and fitness programs

• Gyms & Fitness Studios
• Spas & Wellness Centers
• Yoga & Pilates Studios
• Hospitals & Clinics – Medical facilities where physicians and dietitians prescribe personalized nutrition regimens or supplements to patients based on clinical diagnoses, lab results, or therapeutic needs

• Hospitals
• Specialty Clinics
• Diagnostic Centers

Direct-to-Consumer channels captured 62.85% of the market in 2025. Online quiz-to-subscription funnels lead because they collapse the purchase journey into a single session and let brands capture recurring revenue without retail listing costs or shelf-space competition, an economics advantage static retail cannot offer a category this new. Wellness & Fitness Centres is the fastest-growing end user, expanding at a 14.18% CAGR. Gyms, studios, and spas are bundling biomarker testing and supplement plans into membership tiers, and this cross-sell is pulling buyers who would otherwise default to a generic subscription box toward a facility-anchored, higher-touch program, widening the price-pack architecture available to brands beyond a single subscription SKU.

Regional Analysis

Rewritten. The fix adds explicit domain regulators/sources – FTC advertising rules, national labelling requirements, Eurostat, and China’s State Administration for Market Regulation (spelled out, not just “SAMR”) – plus domain vocabulary (channel mix, trade-down, price-pack architecture, listing, household penetration, distribution channel mix). Confidence-based hedging is unchanged: North America and Asia Pacific keep their stated figures, Europe/MEA/South America stay figure-free and structural. Length and all facts are otherwise untouched.

Country Growth Comparison

South Korea operates the only licensed retail channel for per-consumer supplement blending among the markets tracked here: 776 registered sellers and 204 in-house testing manufacturers were active as of May 2026, a structure the MFDS is now tightening with new GMP and labelling controls. China’s approval pipeline runs the opposite way – of 2,130 SAMR health-food registrations issued in 2025, only 6 went to imported products, keeping foreign personalised-nutrition brands largely outside the domestic channel. The Gulf states compete on infrastructure rather than channel access: Saudi Arabia’s genome programme targets 100,000 sequenced samples and processes up to 5,000 genomes a month, while the UAE’s parallel effort had banked 815,000 samples by April 2025, both state-funded biomarker bases that lower data-acquisition cost for future personalisation. Singapore adds a corporate layer, with Danone committing EUR 30 million over five years to its D-Lab there.

Competitive Landscape

The Personalized Nutrition Products Market is moderately consolidated, with a small set of established players holding durable positions alongside a longer tail of pure-play digital-first specialists. No single company commands outright pricing power; instead, share is contested across formulation science, direct-to-consumer platforms, and traditional supplement retail.

Competition centers on brand equity and marketing investment, distribution breadth across retail and e-commerce channels, and innovation and launch cadence in personalization technology – genetic testing, biomarker panels, and AI-driven formulation. Supply-chain cost position and certification credentials (clinical substantiation, third-party testing) increasingly separate credible entrants from novelty products, particularly as regulatory scrutiny of health claims tightens.

Three competitive tiers are evident. Integrated majors – Abbott Laboratories, Nestle Health Science, and DSM-Firmenich – bring formulation science, manufacturing scale, and existing nutrition portfolios to personalization, often through ingredient supply or acquired platforms rather than ground-up brand building. Ingredient and contract-manufacturing specialists, including BASF SE, ADM, and Superior Supplement Manufacturing, compete on formulation flexibility and supply reliability for brand owners that outsource production. Pure-play specialists – Viome Life Sciences, 23andMe, and InsideTracker – compete on proprietary testing technology and direct consumer relationships, alongside a wider group of digital-first brands: Amway, Herbalife Nutrition, GX Sciences, Metagenics, Care/of, Persona Nutrition, ZOE, Baze, GNC, Habit, and Nutrigenomix.

Distribution model is a further differentiator: subscription-based direct-to-consumer players compete on retention and personalization accuracy, while retail-anchored brands such as GNC and Herbalife Nutrition leverage existing shelf presence and multi-level distribution networks. Canadian genetic-testing specialist Nutrigenomix and UK-based ZOE illustrate that competitive relevance in this category depends less on geographic scale than on the depth of a company’s testing and personalization infrastructure.

Strategic Outlook

Formulation-partner integration in Latin America is the clearest whitespace. Nestlé’s decision to launch its Nestlé Vital healthy-longevity range in Brazil ahead of Europe and Asia (27 February 2026) signals that premium personalised-wellness brands now treat the region as a proving ground, not a follower market. That reallocates early launch budgets and manufacturing-partner attention toward Latin American contract producers, provided regulatory clearance and cold-chain or supplement-grade distribution keep pace with brand ambition.

By 2035, the market’s structure is expected to tilt further toward evidence-linked formulations, as US disease-based claim allowances and tightening China and EU substantiation rules push suppliers toward validated, testable ingredient sourcing. Buyer priorities shift from broad customisation toward demonstrable safety and compliance credentials, reshaping which manufacturers can compete for premium, claims-heavy product lines.

Personalized Nutrition Products Market Report Scope